Steven Li Pharmaceutical Insightshttps://stevenyiqingli.com/en/insights/2026-07-20T00:00:00ZBuilding Sustainable Pharmaceutical Partnerships in Southeast Asiahttps://stevenyiqingli.com/en/insights/sustainable-pharma-partnerships-southeast-asia.html2026-07-19T00:00:00Z2026-07-19T00:00:00ZA stage-gated framework for market, regulatory, technical, quality and commercial cooperation in Southeast Asia.Steven Li (李一青)Driving Localized Manufacturing Through Technology Transferhttps://stevenyiqingli.com/en/insights/technology-transfer-localized-manufacturing.html2026-07-19T00:00:00Z2026-07-19T00:00:00ZA lifecycle approach to pharmaceutical technology transfer, scale-up, validation and receiving-site capability.Steven Li (李一青)Quality Systems as the Foundation of Cross-Border Pharmaceutical Partnershipshttps://stevenyiqingli.com/en/insights/quality-systems-cross-border-partnerships.html2026-07-19T00:00:00Z2026-07-19T00:00:00ZHow clear quality governance, evidence and change control support durable cross-border pharmaceutical partnerships.Steven Li (李一青)Evaluating Sterile Injectable CMO/CDMO Projectshttps://stevenyiqingli.com/en/insights/sterile-injectable-cmo-cdmo-project-evaluation.html2026-07-20T00:00:00Z2026-07-20T00:00:00ZA stage-gated route from non-confidential fit screening to transfer, validation and commercial readiness.Steven Li (李一青)CMO, CDMO or Technology Transfer? A Practical Selection Frameworkhttps://stevenyiqingli.com/en/insights/cmo-cdmo-technology-transfer-selection.html2026-07-20T00:00:00Z2026-07-20T00:00:00ZA practical framework for selecting a cooperation model by product maturity, evidence gaps, regulatory responsibility and operating end state.Steven Li (李一青)What Responsibilities Should a Pharmaceutical Contract Manufacturing Quality Agreement Define?https://stevenyiqingli.com/en/insights/pharmaceutical-quality-agreement-responsibilities.html2026-07-20T00:00:00Z2026-07-20T00:00:00ZA practical responsibility matrix for quality governance, release, change, investigations, records, audits and lifecycle control.Steven Li (李一青)What Non-Confidential Information Is Needed for a Preliminary CMO/CDMO Project Assessment?https://stevenyiqingli.com/en/insights/cmo-cdmo-preliminary-assessment-nonconfidential-information.html2026-07-20T00:00:00Z2026-07-20T00:00:00ZA safe first-contact checklist for screening project fit before sensitive technical disclosure.Steven Li (李一青)How to Evaluate a Sterile Pharmaceutical Contract Manufacturerhttps://stevenyiqingli.com/en/insights/evaluating-sterile-pharmaceutical-contract-manufacturer.html2026-07-20T00:00:00Z2026-07-20T00:00:00ZA site-due-diligence framework for sterility assurance, facility fit, quality systems, evidence and supply resilience.Steven Li (李一青)Due Diligence Checklist for Overseas Pharmaceutical Companies Selecting a Manufacturing Partner in Chinahttps://stevenyiqingli.com/en/insights/due-diligence-chinese-pharmaceutical-manufacturing-partner.html2026-07-20T00:00:00Z2026-07-20T00:00:00ZA staged verification framework for selecting a named Chinese legal entity and manufacturing site for a defined product and market.Steven Li (李一青)